Goldman’s Chief Economist To Cut GDP Forecast Again
S&P Disagrees With The Fed on Banks Raising Dividends
RBC: Apple iPAD’s “Selling like Hotcakes”
via Briefing:
Comments »Apple Q2 preview; iPads outselling hotcakes; FY11 ests raised – RBC Capital Mkts (332.20 +1.40)
RBC notes, on pent-up iPad2 demand, VZ iPhone, and Macbook Air uptake, it expects $24.0 bln rev and $5.75 EPS, above street ($23.2B, $5.33) and guidance. With 8M iPad 2 shipments expected, Q3 revenue guidance expected at $23-24B (46-53% Y/Y), inline with street ($23.8B). EPS guidance expected below street ($4.50-4.70, street $5.28) with 36% Q3 margin guidance and September iPhone 5 timing. On higher iPads (31M vs. 25M prior), its F11 ests become $102B rev and $23.55 EPS (prior $99/$23.30;$100.4/$23.02 consensus).
Top Analyst Upgrades and Downgrades: CIEN, GMCR, MCP, NFLX, NVDA, SBUX, AMD, BRCM, MU, NVDA, SMH
Dollar and Oil Fall 6ft Under Together
Goldman: Sell Brent Down to $105
Goldman cuts Morgan Stanley Profit for Q2
U.S. Milk Supplies Found With Radiation Levels 300 Times Legal Limit
Highly Concentrated Cloud of Cesium Forming Over California (video)
Gas Fracking Effecting More Than Just The Properties Being Drilled
U.S. Accused Again of Utilizing Al-Qaeda as Allies in Libya
Blackwater Style Group to Enter Libya
Crack Spreads Are Blowing Out
Spreads are up another 4.3% this morning to a high of $26.31.
Comments »CSCO to Restructure Consumer Business
Blackstone and Alta resources to Invest $1B in Unconventional Oil and Gas Plays
Upgrades and Downgrades This Morning
Upgrades
CAT – Caterpillar: Hearing upgraded to Buy at boutique firm
GOOG – Google 1Q11 preview: modest upside driven by paid clicks, international search, and display – Wedbush
ONXX – Onyx Pharma initiated with a Buy at Maxim Group; tgt $43
T – AT&T iPhone impact not as bad as we expected – Hudson Square
LDK – LDK Solar: Incremental data points provide upside to their forecast – Kaufman
BIIB – Biogen Idec ticking higher; strength attributed to tier 1 firm upgrade
TSO – Tesoro ests and tgt raised to $18 at The Benchmark Company 25.65
ENDP – Endo Pharm target raised to $48 from $42 at Oppenheimer
Downgrades
AON – Aon downgraded to Neutral from Buy at Sterne Agee -target $60
ANF – Abercrombie & Fitch downgraded to Hold at Argus
ELN – Elan downgraded to Neutral from Buy at UBS
SNE – Sony downgraded to Hold at Maxim Group
IOC – InterOil downgraded to Market Perform from Outperform at Raymond James
NYX – NYSE Euronext tgt trimmed to $43 at Argus following Nasdaq/ICE offer
MCRL – Micrel target lowered to $14 from $16 at Stifel Nicolaus
PAL – N Amer Palladium downgraded to Hold at Stifel Nicolaus
AMMD – American Medical downgraded to Hold at Stifel Nicolaus
KO – Coca-Cola removed from U.S Key call list at UBS
Comments »Gapping Up and Down This Morning
Gapping Up
LVLT +3.5%, SKBI +2.0%, WBMD +1.2%, : AVII +5.6%, DDS +0.8%, HUN +1.1%, EXEL +12.1%, TIBX +3.7%, ZNH +6.8%, CEA +5.5%, GMXR +9.6%, CYH +2.4%, CUK +2.0%, CCL +1.2%, AWH +0.8%
Gapping Down
F -1.7%, JOEZ -9.7%, AA -3.8%, EXTR -18.3%, MCRL -13.5%, TUES -11.1%, CSX -1.3%, MS -0.9%, CSX -1.3%, ELN -1.6%, SD -3.4%, SSL -2.9%, PTR -2.8%, RDS.A -2%, BP -1.6%, BBL -2%, RIO -1.9%, BHP -1.4%, GG -1.2%, PAL -1.2%, PAAS -1.1%, MT -1%, VALE -1%, LYG -3.0%, AIB -2.6%, IRE -2.4%, SB -7.1%, CBEH -7%, ECT -4.8%,
Comments »
